Key events in RNAi therapeutics mapped to the Technology Curve

Oligonucleotide Therapeutics: Technology Evolution for Clinically Relevant Tissue Delivery

Anastasia Khvorova, PhD, is Professor in the RNA Therapeutics Institute and the Program in Molecular Medicine at the University of Massachusetts Medical School (UMMS) in Worcester, Massachusetts. Before joining the UMMS faculty, she held leadership positions in industry, including VP of Research & Development and CSO of Dharmacon (now a Thermo Fisher Scientific company), Founder…